Clintabs label

Clintabs

Clintabs Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

Keep out of reach of children. Not for human use.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

Clintabs (brand of clindamycin hydrochloride) Tablets (for use in dogs only) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below:

Dogs

Skin infections (wounds and abscesses) due to: coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius).

Deep wounds and abscesses due to Bateroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Dental infections due to Staphyloccus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Osteomyelitis due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

Clintabs Tablets contain clindamycin hydrochloride which is the hydrated salt of clindamycin. Clindamycin is a semisyntheic antibiotic produced by a 7(S)-chlorosubstitution of the 7(R)-hydroxyl group of a naturally produced antibiotic produced by Streptomyces lincolnensis var. lincolnensis.

Clintabs Tablets (For Use in Dogs Only)

25 mg Tablet, each white bisected tablet is marked “C” above the bisect and “25” below the bisect and contains clindamycin hydrochloride equivalent to 25 mg of clindamycin.

75 mg Tablet, each white bisected tablet is marked “C” above the bisect and “75” below the bisect and contains clindamycin hydrochloride equivalent to 75 mg of clindamycin.

150 mg Tablet, each white tablet is marked “C 150” on one side and contains clindamycin hydrochloride equivalent to 150 mg of clindamycin.

Add Info
Add to My Alerts
Report Side Effect
Leave a Review

Is this a good medication?

Rated 5 out of 5
5.00
out of Five Stars
1
Rating(s)
Navigate to :
Clintabs Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Clintabs Manufacturers

  • Virbac Ah, Inc.
    Clintabs | Virbac Ah, Inc.
    No Recall

    Clintabs | Virbac Ah, Inc.

    Clintabs | Virbac Ah, Inc.
    Dogs Infected Wounds, Abscesses, and Dental Infections Oral

    2.5-15.0 mg/lb body weight every 12 hours.

    Duration

    Treatment with clindamycin hydrochloride products may be continued up to a maximum of 28 days if clinical judgment indicates. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen.

    Dosage Schedule Tablets

    Clintabs 25 mg, administer 1-6 tablets every 12 hours for each 10 pounds of body weight.

    Clintabs 75 mg, administer 1-6 tablets every 12 hours for each 30 pounds of body weight.

    Clintabs 150 mg, administer 1-6 tablets every 12 hours for each 60 pounds of body weight.

    Dogs Osteomyelitis Oral

    5.0-15.0 mg/lb body weight every 12 hours.

    Duration

    Treatment with clindamycin hydrochloride is recommended for a minimum of 28 days. Treatment should not be continued for longer than 28 days if no response to therapy is seen.

    Dosage Schedule Tablets

    Clintabs 25 mg, administer 2-6 tablets every 12 hours for each 10 pounds of body weight.

    Clintabs 75 mg, administer 2-6 tablets every 12 hour for each 30 pounds of body weight.

    Clintabs 150 mg, administer 2-6 tablets every 12 hours for each 60 pounds of body weight.

Login To Your Free Account